APA
RUBY

American Portfolios Advisors’s Rubius Therapeutics, Inc RUBY Stock Holding History

American Portfolios Advisors’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$141 Hold
325
– – ﹤0.01% 3474
2022
Q2 		$276 Hold
325
– – ﹤0.01% 3449
2022
Q1 		$1.79K Hold
325
– – ﹤0.01% 3250
2021
Q4 		$3.15K Buy
+325
New +$4.51K ﹤0.01% 3048
2020
Q2 		– Sell
-487
Closed -$2.17K – 2908
2020
Q1 		$2.17K Buy
+487
New +$3.62K ﹤0.01% 2370

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

American Portfolios Advisors's RUBY Position: Q3 2022 in Review

American Portfolios Advisors held its Rubius Therapeutics, Inc (RUBY) position steady in Q3 2022 at 325 shares worth $141. The position accounts for ﹤0.01% of the portfolio, ranked #3474.

American Portfolios Advisors first reported a position in RUBY in Q1 2020 and has held it in 5 quarters since. The position peaked at $3.15K in Q4 2021. 62 funds tracked by Wall St. Rank hold RUBY as of Q3 2022.

  • American Portfolios Advisors held 325 shares of Rubius Therapeutics, Inc worth $141 as of Q3 2022.
  • American Portfolios Advisors left its Rubius Therapeutics, Inc share count unchanged in Q3 2022.
  • Rubius Therapeutics, Inc made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3474 holding.
  • American Portfolios Advisors first reported a position in Rubius Therapeutics, Inc in Q1 2020 and has held it in 5 quarters since.
  • American Portfolios Advisors's Rubius Therapeutics, Inc position peaked at $3.15K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.